Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
35.97 M EUR
224.92 M EUR
1.39 M
About CLINICA BAVIERA S.A.
Sector
Industry
CEO
Eduardo Baviera Sabater
Website
Headquarters
Madrid
Founded
1992
ISIN
ES0119037010
FIGI
BBG000PGB2C6
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CBAV is 34.7 EUR — it has decreased by −0.86% in the past 24 hours. Watch CLINICA BAVIERA S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange CLINICA BAVIERA S.A. stocks are traded under the ticker CBAV.
CBAV stock has risen by 3.58% compared to the previous week, the month change is a −1.14% fall, over the last year CLINICA BAVIERA S.A. has showed a 72.64% increase.
CBAV reached its all-time high on Oct 21, 2024 with the price of 39.5 EUR, and its all-time low was 3.6 EUR and was reached on Dec 14, 2012. View more price dynamics on CBAV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CBAV stock is 4.11% volatile and has beta coefficient of 0.45. Track CLINICA BAVIERA S.A. stock price on the chart and check out the list of the most volatile stocks — is CLINICA BAVIERA S.A. there?
Today CLINICA BAVIERA S.A. has the market capitalization of 565.69 M, it has decreased by −5.71% over the last week.
Yes, you can track CLINICA BAVIERA S.A. financials in yearly and quarterly reports right on TradingView.
CLINICA BAVIERA S.A. is going to release the next earnings report on Nov 15, 2024. Keep track of upcoming events with our Earnings Calendar.
CBAV net income for the last quarter is 12.41 M EUR, while the quarter before that showed 11.61 M EUR of net income which accounts for 6.97% change. Track more CLINICA BAVIERA S.A. financial stats to get the full picture.
CLINICA BAVIERA S.A. dividend yield was 5.53% in 2023, and payout ratio reached 57.64%. The year before the numbers were 6.03% and 58.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 9, 2024, the company has 1.47 K employees. See our rating of the largest employees — is CLINICA BAVIERA S.A. on this list?
Like other stocks, CBAV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINICA BAVIERA S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLINICA BAVIERA S.A. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLINICA BAVIERA S.A. stock shows the buy signal. See more of CLINICA BAVIERA S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.